Bio Risk
Bio risk refers to the risk associated with biological materials and/or infectious agents. Lately the term is also used within the laboratory setting combining the term biological safety (biosafety) and biosecurity into one word. Bio risk is a DNV-trademarked term in Norway. The term is now gaining increasing recognition amongst regulators, laboratory personnel and industry alike and is used by the WHO. An international Laboratory Bio risk Management Standard developed under the auspices of the European Committee for Standardization defines bio risk as the combination of the probability of occurrence of harm and the severity of that harm where the source of harm is a biological agent or toxin. The source of harm may be an unintentional exposure, accidental release or loss, theft, misuse, diversion, unauthorized access or intentional unauthorized release.
Related Conference of Bio Risk
November 13-14, 2025
8th International Conference on Global Toxicology and Risk Assessment
Amsterdam, Netherlands
November 27-28, 2025
7th International Conference on Clinical Pharmacology and Toxicology
Zurich, Switzerland
Bio Risk Conference Speakers
Recommended Sessions
Related Journals
Are you interested in
- Adverse Drug Reactions and Pharmacovigilance - clinical pharmacology 2025 (Switzerland)
- Cardiovascular Pharmacology - clinical pharmacology 2025 (Switzerland)
- Clinical Toxicology of Drugs of Abuse - clinical pharmacology 2025 (Switzerland)
- Clinical Trials and Regulatory Affairs - clinical pharmacology 2025 (Switzerland)
- Drug Interactions and Polypharmacy - clinical pharmacology 2025 (Switzerland)
- Emerging Trends in Clinical Pharmacology - clinical pharmacology 2025 (Switzerland)
- Environmental and Occupational Toxicology - clinical pharmacology 2025 (Switzerland)
- Future Directions in Clinical Pharmacology and Toxicology - clinical pharmacology 2025 (Switzerland)
- Innovations in Drug Development and Therapeutics - clinical pharmacology 2025 (Switzerland)
- Natural Products and Toxicology - clinical pharmacology 2025 (Switzerland)
- Neuropharmacology and Toxicology - clinical pharmacology 2025 (Switzerland)
- Pediatric and Geriatric Pharmacology - clinical pharmacology 2025 (Switzerland)
- Pharmacogenomics and Personalized Medicine - clinical pharmacology 2025 (Switzerland)
- Pharmacokinetics and Pharmacodynamics - clinical pharmacology 2025 (Switzerland)
- Toxicology and Risk Assessment - clinical pharmacology 2025 (Switzerland)